Device type · PDJ
Hemoglobin A1c Test System
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
PDJ
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
23
510(k), De Novo and PMA
Adverse event reports
94
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Hemoglobin A1c Test System
- Product code
- PDJ
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1373
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for PDJ
Latest FDA decisions
The 8 newest of 23 since 2015.
Shenzhen Lifotronic Technology Co., Ltd.
K260468 · Decided Oct 2, 2026 · 232 days after receipt
Device type: Hemoglobin A1c Test System (PDJ) · Laboratory Medicine & Pathology
Shanghai Medconn Medical Technology Co., Ltd.
K252749 · Decided Jan 6, 2026 · 130 days after receipt
Device type: Hemoglobin A1c Test System (PDJ) · Laboratory Medicine & Pathology
K250073 · Decided Oct 3, 2025 · 266 days after receipt
Device type: Hemoglobin A1c Test System (PDJ) · Laboratory Medicine & Pathology
Shanghai Medconn Medical Technology Co., Ltd.
K242911 · Decided Jun 20, 2025 · 269 days after receipt
Device type: Hemoglobin A1c Test System (PDJ) · Laboratory Medicine & Pathology
Shijiazhuang Hipro Biotechnology Co., Ltd.
K220999 · Decided Sep 12, 2024 · 892 days after receipt
Device type: Hemoglobin A1c Test System (PDJ) · Laboratory Medicine & Pathology
K200904 · Decided Aug 5, 2021 · 486 days after receipt
Device type: Hemoglobin A1c Test System (PDJ) · Laboratory Medicine & Pathology
Siemens Healthcare Diagnostics, Inc.
K200256 · Decided Jul 2, 2021 · 515 days after receipt
Device type: Hemoglobin A1c Test System (PDJ) · Laboratory Medicine & Pathology
Roche Diagnostics Operations (Rdo)
K193053 · Decided Mar 26, 2020 · 146 days after receipt
Device type: Hemoglobin A1c Test System (PDJ) · Laboratory Medicine & Pathology
Reports received
94
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
94
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 2 | 0 | 0 | 0 |
| Jan 24 | 2 | 0 | 0 | 0 |
| Feb 24 | 1 | 0 | 0 | 0 |
| Mar 24 | 6 | 0 | 0 | 0 |
| Apr 24 | 4 | 0 | 0 | 0 |
| May 24 | 2 | 0 | 0 | 0 |
| Jun 24 | 4 | 0 | 0 | 0 |
| Jul 24 | 6 | 0 | 0 | 0 |
| Aug 24 | 2 | 0 | 0 | 0 |
| Sep 24 | 3 | 0 | 0 | 0 |
| Oct 24 | 7 | 0 | 0 | 0 |
| Nov 24 | 5 | 0 | 0 | 0 |
| Dec 24 | 5 | 0 | 0 | 0 |
| Jan 25 | 1 | 0 | 0 | 0 |
| Feb 25 | 1 | 0 | 0 | 0 |
| Mar 25 | 5 | 0 | 0 | 0 |
| Apr 25 | 3 | 0 | 0 | 0 |
| May 25 | 6 | 0 | 0 | 0 |
| Jun 25 | 2 | 0 | 0 | 0 |
| Jul 25 | 1 | 0 | 0 | 0 |
| Aug 25 | 2 | 0 | 0 | 0 |
| Sep 25 | 3 | 0 | 0 | 0 |
| Oct 25 | 4 | 0 | 0 | 0 |
| Nov 25 | 2 | 0 | 0 | 0 |
| Dec 25 | 12 | 0 | 0 | 0 |
| Jan 26 | 6 | 0 | 0 | 0 |
| Feb 26 | 5 | 0 | 0 | 0 |
| Mar 26 | 5 | 0 | 0 | 0 |
| Apr 26 | 7 | 0 | 0 | 0 |
| May 26 | 7 | 0 | 0 | 0 |
| Jun 26 | 13 | 0 | 0 | 0 |
| Jul 26 | 6 | 0 | 0 | 0 |
| Aug 26 | 2 | 0 | 0 | 0 |
| Sep 26 | 12 | 0 | 0 | 0 |
| Oct 26 | 17 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- High Test Results46
- Incorrect, Inadequate or Imprecise Result or Readings29
- Low Test Results22
- Device Ingredient or Reagent Problem3
- Complete Loss of Power1
- Device Emits Odor1
- Incorrect Measurement1
- Material Fragmentation1
- Non Reproducible Results1
- Patient Device Interaction Problem1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions93
- Device Embedded In Tissue or Plaque1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Siemens Healthcare Diagnostics, Inc.
Z-2703-2026 · Started Jun 8, 2026 · Posted by FDA Jul 8, 2026
Reason given: The potential for intermittent well-to-well bias on the A1c_E assay on the Atellica CH and Atellica CI analyzer which could cause falsely depressed or falsely elevated HbA1c patient results.
Cause as FDA categorized it: Under Investigation by firm
- Atellica CH Enzymatic Hemoglobin A1c (A1c_E); Siemens Material Number (SMN): 11097536;Open, Classified
Siemens Healthcare Diagnostics, Inc.
Z-1657-2026 · Started Feb 23, 2026 · Posted by FDA Mar 27, 2026
Reason given: A potential for depressed results for Atellica CH A1c_E when processing Atellica CH RCRP on the same analyzer. Customers processing A1c_E and RCRP on separate analyzers are not impacted by the recall. The frequency and magnitude of the negative bias and imprecision increase over time and are not consistent with the...
Cause as FDA categorized it: Process control
Ortho-Clinical Diagnostics, Inc.
Z-1628-2023 · Started Apr 17, 2023 · Posted by FDA May 24, 2023
Reason given: Potential for both unexpected positive and negative HbA1c results, may result in misdiagnosis
Cause as FDA categorized it: Under Investigation by firm
- REF: 4P52-20 Hemoglobin A1c for use with Architect, IVD, CE, R1 1 x 52 mL, R2 1 x 20 mL, A1cDL 2 x 35 mLOpen, Classified
Z-1454-2022 · Started Jun 9, 2022
Reason given: There is a potential for falsely elevated Hemoglobin %A1c and Hemoglobin A1c results to be generated using the ARCHITECT and Alinity c Hemoglobin A1c assay.
Cause as FDA categorized it: Under Investigation by firm
- REF: 08P4320, Alinity c Hemoglobin Reagent Kit, IVD, CE, R1 5 x 46.0 mL, R2 5 x 18.3 mL, A1cDL 5 x 67.6 mLOpen, Classified
Z-1455-2022 · Started Jun 9, 2022
Reason given: There is a potential for falsely elevated Hemoglobin %A1c and Hemoglobin A1c results to be generated using the ARCHITECT and Alinity c Hemoglobin A1c assay.
Cause as FDA categorized it: Under Investigation by firm
- REF: 08P4377, Alinity c Hemoglobin Reagent Kit, IVD, CE, R1 5 x 46.0 mL, R2 5 x 18.3 mL, A1cDL 5 x 67.6 mLOpen, Classified
Z-1456-2022 · Started Jun 9, 2022
Reason given: There is a potential for falsely elevated Hemoglobin %A1c and Hemoglobin A1c results to be generated using the ARCHITECT and Alinity c Hemoglobin A1c assay.
Cause as FDA categorized it: Under Investigation by firm
- Atellica CH Enzymatic Hemoglobin A1c (A1c_E/A1c_H), Siemens Material Number 11097536Open, Classified
Siemens Healthcare Diagnostics, Inc.
Z-0929-2022 · Started Feb 9, 2022
Reason given: Siemens Healthcare Diagnostics Inc. has confirmed the potential for reagent carryover impacting quality control (QC), patient samples, and calibrator results.
Cause as FDA categorized it: Device Design
Abbott Diagnostics Technologies AS
Z-2192-2020 · Started Mar 23, 2020
Reason given: The analyzer system may have an electrostatic discharge and sparking of the power supply provided with the analyzers resulting in the power supply becoming non-functional.
Cause as FDA categorized it: Device Design
Showing the 8 newest of 9 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.